Home > Boards > US Listed > Biotechs > Moderna Inc. (MRNA)

Nice! mRNA based immunotherapies is a game changer.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Trend-Setter Member Profile
 
Followed By 4
Posts 680
Boards Moderated 0
Alias Born 07/19/13
160x600 placeholder
Moderna to Present at ROTH RNA Revolution Conference Business Wire - 7/10/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 4:36:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 4:34:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 4:32:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 4:29:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 4:17:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 4:15:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 4:13:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 4:12:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/27/2019 4:07:27 PM
Moderna to Present at BMO 2019 Prescriptions for Success Healthcare Conference Business Wire - 6/18/2019 8:00:00 AM
Moderna to Present at Goldman Sachs 40th Annual Global Healthcare Conference Business Wire - 6/7/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2019 6:31:48 AM
Moderna Announces Presentation of Interim Data from Phase 1 Study of mRNA Personalized Cancer Vaccine at 2019 ASCO Annual Me... Business Wire - 6/1/2019 9:00:00 AM
Moderna Announces Publication of Preclinical Data for Chikungunya Antibody Program Business Wire - 5/17/2019 2:01:00 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 5/15/2019 5:38:15 PM
Moderna Announces Publication of Phase 1 Data for mRNA Vaccines Against Two Potential Pandemic Influenza Strains Business Wire - 5/10/2019 9:00:00 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 5/9/2019 6:14:39 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/8/2019 7:01:03 AM
Moderna Reports First Quarter 2019 Financial Results and Provides Business Updates Business Wire - 5/8/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2019 6:53:37 AM
Moderna to Present at Bank of America Merrill Lynch 2019 Health Care Conference Business Wire - 5/6/2019 8:00:00 AM
Moderna to Present Preclinical Data at 2019 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting Business Wire - 4/29/2019 8:00:00 AM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/25/2019 5:18:05 PM
Moderna to Host Science Day on May 7, 2019 and Report First Quarter Financial Results on May 8, 2019 Business Wire - 4/16/2019 8:00:00 AM
Trend-Setter   Wednesday, 12/19/18 11:45:43 AM
Re: Drugdoctor post# 3
Post # of 35 
Nice! mRNA based immunotherapies is a game changer. The science is gaining more attention in pursuit of prevention and cure for cancers, allergies,and infectious diseases. Keeping an eye on MRNA.

here are some latest deals to include:
https://www.etherna.be/newsroom/news/155-mymetics-starts-research-collaboration-project-in-cancer-immunotherapy-with-etherna

https://xconomy.com/boston/2018/06/11/with-45m-translate-bio-deal-sanofi-bets-again-on-mrna-vaccines/

https://xconomy.com/new-york/2018/08/16/with-biontech-deal-pfizer-becomes-latest-to-bet-on-mrna-vaccines/

good to see you here fellow elite p!

GL

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist